Abstract:The aim of this paper was to explore the effects of triptolide( TP),the effective component of Tripterygium wilfordii on improving podocyte epithelial-mesenchymal transition( EMT) induced by high glucose( HG),based on the regulative mechanisms of Nod-like receptor protein 3( NLRP 3) inflammasome in the kidney of diabetic kidney disease( DKD). The immortalized podocytes of mice in vitro were divided into the normal( N) group,the HG( HG) group,the low dose of TP( L-TP) group,the high dose of TP( HTP) group and the mannitol( MNT) group,and treated by the different measures,respectively. More specifically,the podocytes in each group were separately treated by D-glucose( DG,5 mmol·L~(-1)) or HG( 30 mmol·L~(-1)) or HG( 30 mmol·L~(-1)) + TP( 5 μg·L~(-1))or HG( 30 mmol·L~(-1)) + TP( 10 μg·L~(-1)) or DG( 5 mmol·L~(-1)) + MNT( 24. 5 mmol·L~(-1)). After the treatment of HG or TP at 24,48 and 72 h,firstly,the activation of podocyte proliferation was investigated. Secondly,the protein expression levels of the epithelial markers in podocytes such as nephrin and ZO-1,the mesenchymal markers such as collagen Ⅰ and fibronectin( FN) were detected,respectively. Finally,the protein expression levels of NLRP3 and apoptosis-associated speck-like protein( ASC) as the key signaling molecules of NLRP3 inflammasome activation,as well as the downstream effector proteins including caspase-1,interleutin( IL)-1β and IL-18 were examined,severally. The results indicated that,for the cultured podocytes in vitro,HG could cause the low protein expression levels of nephrin and ZO-1,induce the high protein expression levels of collagen Ⅰ and FN and trigger podocyte EMT. Also HG could cause the high protein expression levels of NLRP3,ASC,caspase-1,IL-1β and IL-18 and induce NLRP3 inflammasome activation. On the other hand,the co-treatment of TP( L-TP or H-TP) and HG for podocytes could recover the protein expression levels of nephrin and ZO-1,inhibit the protein expression levels of collagen Ⅰ and FN and ameliorate podocyte EMT. Also the co-treatment of TP( L-TP or H-TP) and HG could down-regulate the protein expression levels of NLRP3 and ASC,inhibit NLRP3 inflammasome activation and reduce the protein expression levels of the downstream effector molecules including caspase-1,IL-1β and IL-18. On the whole,HG could activate NLRP3 inflammasome and induce podocyte EMT in vitro. TP at the appropriate dose range could inhibit NLRP3 inflammasome activation and ameliorate podocyte EMT,which may be one of the critical molecular mechanisms of TP protecting againstpodocyte inflammatory injury in DKD.

Tripterygium Glycoside Protects Against Puromycin Amino Nucleoside-Induced Podocyte Injury By Upregulating Autophagy

Tripterygium glycoside protects diabetic kidney disease mouse serum-induced podocyte injury by upregulating autophagy and downregulating β-arrestin-1.

Triptolide protects podocytes via autophagy in immunoglobulin A nephropathy.

Tripterygium Glycoside Suppresses Epithelial-to-mesenchymal Transition of Diabetic Kidney Disease Podocytes by Targeting Autophagy Through the Mtor/twist1 Pathway

Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro.

Triptolide Potentiates the Cytoskeleton-Stabilizing Activity of Cyclosporine A in Glomerular Podocytes Via a GSK3 Dependent Mechanism

Triptolid ameliorate podocyte injury induced by puro mycin aminonucleoside in vitro

[Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose]

Pharmacological Targeting of GSK3β Confers Protection Against Podocytopathy and Proteinuria by Desensitizing Mitochondrial Permeability Transition

Therapeutic effect of triptolide on podocyte injury in nephrosis rats induced by puromycin aminonucleoside

Triptolide Protects Podocytes from Injury

Triptolide Protects Podocytes from TGF-β-induced Injury by Preventing Mir-30 Downregulation.

Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.

Yi Qi Qing Re Gao Attenuates Podocyte Injury and Inhibits Vascular Endothelial Growth Factor Overexpression in Puromycin Aminonucleoside Rat Model

Effects of tacrolimus on autophagy protein LC3 in puromycin-damaged mouse podocytes

Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3 Beta Reinforces the Nrf2 Antioxidant Defense Against Podocytopathy

PPARα Agonist Exerts Protective Effects in Podocyte Injury Via Inhibition of the ANGPTL3 Pathway.

Triptolide attenuates proteinuria and podocyte apoptosis via inhibition of NF-κB/ GADD45B

Differential toxicities of triptolide to immortalized podocytes and the podocytes in vivo.

Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro.

Notoginsenoside R1 Attenuates Glucose-Induced Podocyte Injury Via the Inhibition of Apoptosis and the Activation of Autophagy Through the Pi3k/Akt/Mtor Signaling Pathway